Oncology is one of the therapeutic fields with the most ongoing clinical trials and the most rapidly-evolving field. This can make it challenging for a biotech company to break through the crowded landscape to engage productively with clinical investigators and oncologists.
Moderated by a practicing oncologist at Massachusetts General Hospital, panelists will describe how they have effectively networked and connected with key opinion leaders in the areas of oncology, in order to constructively engage with oncology experts for the ‘win-win’ and to find ways for product candidates to be best evaluated and positioned to make an impact for patients.
Ability Level: All
Session ID: 21191